|
MLTX Moonlake Immunotherapeutics 1821586 |
| Balance Sheet |
|
Current Assets
|
474,288,845 |
|
Assets
|
477,933,282 |
|
Current Liabilities
|
22,463,861 |
|
Liabilities
|
24,542,143 |
|
Equity
|
453,391,139 |
|
Shares Out
|
62,889,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-116,587,263 |
|
Investing Cash Flow
|
-205,595,299 |
| Market Analysis |
Market Cap
|
3,139,893,782 |
|
Price
|
40.62 |
|
BVPS
|
7.21 |
|
PB
|
5.53 |
|
EPS
|
-0.90 |
|
PS
|
0.01 |
|
FCF
|
-322,182,562 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MLTX documents filed with the SEC.
MLTX Filings
Clear
